Eran Segal Selected Research

Eran Segal Research Topics

Disease

13	Neoplasms (Cancer) 12/2023 - 10/2004
6	Type 2 Diabetes Mellitus (MODY) 01/2023 - 10/2020
5	Prediabetic State (Prediabetes) 04/2024 - 11/2015
5	Obesity 05/2022 - 10/2014
5	Dysbiosis 01/2019 - 10/2014
4	Hemorrhage 12/2022 - 12/2002
4	Infections 02/2022 - 05/2007
3	Melanoma (Melanoma, Malignant) 12/2023 - 05/2009
3	Weight Gain 11/2022 - 01/2015
3	Weight Loss (Weight Reduction) 05/2022 - 01/2019
3	COVID-19 12/2021 - 01/2021
3	Glucose Intolerance 01/2015 - 10/2014
3	Critical Illness (Critically Ill) 10/2007 - 12/2002
2	Body Weight (Weight, Body) 08/2023 - 10/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 01/2022
2	Hypersensitivity (Allergy) 01/2023 - 12/2022
2	Sepsis (Septicemia) 02/2022 - 12/2002
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 01/2020
2	Metabolic Diseases (Metabolic Disease) 01/2019 - 10/2014
2	Wounds and Injuries (Trauma) 01/2008 - 12/2002
2	Pulmonary Edema 10/2004 - 07/2004
1	Mental Disorders (Mental Disorder) 12/2023
1	Atrial Fibrillation 12/2022
1	Ischemic Stroke 12/2022
1	Breast Neoplasms (Breast Cancer) 11/2022
1	Cross Infection (Nosocomial Infection) 02/2022
1	Crohn Disease (Crohn's Disease) 01/2022
1	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2022
1	Ulcerative Colitis 01/2022
1	Noncommunicable Diseases 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Sleep Apnea Syndromes (Sleep Apnea) 11/2021
1	Multiple Sclerosis 01/2021
1	Zoonoses 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Atrophy 01/2017
1	Hypopigmentation (Hypomelanosis) 01/2017

Drug/Important Bio-Agent (IBA)

8	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2018
3	AntigensIBA 12/2022 - 01/2021
3	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 10/2020
3	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2007
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 04/2015
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2010 - 10/2004
2	Peptides (Polypeptides)IBA 01/2023 - 01/2021
2	Butyrates (Butyrate)IBA 01/2021 - 01/2019
2	nasIBA 01/2015 - 10/2014
2	Sweetening Agents (Sweeteners)IBA 01/2015 - 10/2014
1	Immune Checkpoint InhibitorsIBA 12/2023
1	LipidsIBA 08/2023
1	EpitopesIBA 01/2023
1	Warfarin (Coumadin)FDA LinkGeneric 12/2022
1	RivaroxabanIBA 12/2022
1	AnticoagulantsIBA 12/2022
1	apixabanIBA 12/2022
1	Immunoglobulin G (IgG)IBA 12/2022
1	Immunoglobulin E (IgE)IBA 12/2022
1	Hormones (Hormone)IBA 11/2022
1	Protein Isoforms (Isoforms)IBA 05/2022
1	Receptor for Advanced Glycation End ProductsIBA 05/2022
1	human esRAGE proteinIBA 05/2022
1	Advanced Glycation End ProductsIBA 05/2022
1	RNA (Ribonucleic Acid)IBA 02/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	FlagellinIBA 01/2022
1	Untranslated Regions (Untranslated Region)IBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Viral RNAIBA 12/2021
1	Oncogene Proteins (Oncogene Protein)IBA 10/2021
1	VaccinesIBA 01/2021
1	BNT162 VaccineIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	AntibodiesIBA 01/2021
1	16S Ribosomal RNAIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 10/2020
1	HDL CholesterolIBA 10/2020
1	LDL CholesterolIBA 10/2020
1	Inositol (Myoinositol)IBA 01/2019
1	Codon (Codons)IBA 01/2018
1	LipofuscinIBA 01/2017

Therapy/Procedure

4	Glycemic Control 12/2023 - 01/2020
3	Therapeutics 11/2022 - 10/2004
2	Immunotherapy 12/2023 - 01/2020
2	Diet Therapy (Therapy, Diet) 08/2023 - 01/2022
2	Mediterranean Diet 11/2022 - 01/2021
2	Fat-Restricted Diet (Diet, Fat Restricted) 01/2022 - 01/2019
2	General Anesthesia 06/2020 - 04/2015
2	Anesthesia 04/2015 - 04/2015
2	Artificial Respiration (Mechanical Ventilation) 03/2010 - 10/2007
1	Reducing Diet 01/2023
1	Caloric Restriction 05/2022
1	Operative Surgical Procedures 02/2022
1	Transplantation 01/2022
1	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 01/2022
1	Polypharmacy 01/2022
1	Aftercare (After-Treatment) 01/2019